Dyne Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
CGEM
Cullinan Oncology, Inc. |
$11.25 | $1.29 B | -7.16 | 85 | $0 |
CYTK
Cytokinetics, Incorporated |
$48.65 | $6.05 B | -9.78 | 423 | $7.53 M |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
DSGN
Design Therapeutics, Inc. |
$4.94 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$1.84 | $647.94 M | -2.83 | 126 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$28.42 | $1.65 B | -11.47 | 108 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.99 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 | $654,000 |
MLYS
Mineralys Therapeutics, Inc. |
$10.36 | $652.38 M | -6.03 | 28 | $0 |
PLRX
Pliant Therapeutics, Inc. |
$10.74 | $672.63 M | -3.9 | 166 | $1.58 M |
RVMD
Revolution Medicines, Inc. |
$40.92 | $6.66 B | -10.51 | 490 | $11.58 M |
STOK
Stoke Therapeutics, Inc. |
$10.51 | $774.50 M | -6.14 | 110 | $8.78 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |